West Pharmaceutical Services Inc.

WST | NYSE

$364.49

+$2.18 (+0.60%)

Sep 21, 2026, 11:50 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	3.07B	2.89B	2.95B	2.89B	2.83B	2.15B
Cost of Revenue	1.97B	1.89B	1.82B	1.75B	1.66B	1.38B
Gross Profit	1.1B	1B	1.13B	1.14B	1.17B	767.9M
Operating Income	617.4M	594.6M	710.9M	763.5M	758.7M	419M
Interest Income	17.7M	19.6M	28M	5.1M	1M	1.4M
Pretax Income	615.3M	600.2M	715.7M	700.6M	769M	418.7M
Net Income	493.7M	492.7M	593.4M	585.9M	661.8M	346.2M
Selling & General & Admin	393.1M	338.5M	353.4M	316.9M	361.9M	302M
Research & Development	74.3M	69.1M	68.4M	58.5M	52.8M	46.9M
Other Expenses	18.5M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	485.9M	407.6M	421.8M	375.4M	414.7M	348.9M
Interest Expense	600K	2.9M	8.8M	7.6M	8.5M	8.5M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.46B	2.3B	2.24B	2.12B	2.07B	1.73B
Income Tax Expense	121.6M	107.5M	122.3M	114.7M	107.2M	72.5M
Shares Outstanding (Basic)	72.3M	73M	74.3M	74.4M	74.4M	73.9M
Shares Outstanding (Diluted)	72.7M	73.7M	75.3M	75.8M	76.3M	75.8M
EPS (Basic)	6.83	6.75	7.99	7.88	8.90	4.68
EPS (Diluted)	6.80	6.69	7.88	7.73	8.67	4.57
EBITDA	723.6M	743.8M	844.1M	808.1M	879.7M	518.9M
EBIT	599.2M	588.4M	706.8M	687.5M	757.4M	409.8M
Depreciation & Amortization	124.4M	155.4M	137.3M	120.6M	122.3M	109.1M